meRfi®-GM
Barrett's esophagus
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Key features:
The cells of Barrett's esophagus are classified into four categories: nondysplastic, low-grade dysplasia, high-grade dysplasia, and frank carcinoma
Gastric esophageal reflux disease (GERD): starting with reflux esophagitis, progressing to Barrett’s esophagus in about 20% of cases, and, in rare cases, proceeding to the development of esophageal adenocarcinoma
…
References (Sources)
- Barrett's Esophagus
- Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
- Esomeprazole and aspirin in Barrett’s oesophagus (AspECT): a randomised factorial trial
- High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome
- Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome
- Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia
- The Human Microbiome Project in 2011 and Beyond